Cancer BiologybioRxivPreprint
CD180 identifies chemoresistant stem-like blasts and reveals a KMT2A-driven vulnerability in acute myeloid leukaemia
Madonna M. Eltoukhy, Alexander Winton, Francesca Fasanella Masci…·Karen Keeshan
This paper identifies CD180 as a marker for chemoresistant stem-like blasts in KMT2A-rearranged paediatric AML, showing its absence on normal HSCs and its role as a therapeutic target.